Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...

With this approval, durvalumab can now be used for treating patients with limited-stage small cell lung cancer (LS-SCLC) ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

Diversion surgery before chemoradiation may be considered for patients with intestinal obstruction or other symptoms that could compromise their likelihood of completing definitive treatment. The ...

Diversion surgery before chemoradiation may be considered for patients with intestinal obstruction or other symptoms that could compromise their likelihood of completing definitive treatment. The ...

Data from the Phase II trial saw three of the seven patients dosed with CAN-2409 surviving for more than 35 months.

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term. Among patients with nonmetastatic, muscle-invasive ...

1Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: Ann H. Klopp, Department of Radiation Oncology, University of Texas MD Anderson ...

The aim of this study was to evaluate the prognostic value of TRG for overall survival (OS) and disease-free survival (DFS) in ESCC patients undergoing neoadjuvant chemoradiation. Methods: The study ...